Apotex has invested over $2 billion to research and development over the past 10 years - more than any other pharmaceutical company in Canada, brand or generic.
In fact, Apotex will continue to lead in these expenditures and has committed over $2.1 billion to research and development over the next 10 years. We do this to ensure that patient needs will continue to be met in the future according to the high standards of quality and overall coverage that we have established.
Find out how being Truly Canadian benefits you: www.trulycanadian.ca
10 ноя 2015
